KaroMab

N/A

Report date: 2025/03/20 20:00:06

Base Information

Drug NameKaroMab
Drug Alias NameGT-Mab 3.2 GEXanticancer MAb (NEMOD)KaroMab-GEXanticancer mAb (Glycotope)
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryGermany
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesNemod
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesNemodGlycotope Gmbh
Active IndicationsN/A
Inactive IndicationsNeoplasms

Other Information

ATC CodeN/A
Related LinksN/A